|
Patent landscape, scope, and claims: |
Patent Analysis for US Patent 11,793,813
What is the scope of US Patent 11,793,813?
US Patent 11,793,813 covers a specific pharmaceutical composition or method involving a candidate drug or therapeutic process. The patent’s claims primarily focus on a novel molecular compound, its chemical structure, and its specific application in treating a targeted disease or condition.
The patent's scope includes:
- The chemical compound identified by a unique structure, often defined by specific chemical groups and stereochemistry.
- Methods of preparing the compound, including synthetic routes and intermediates.
- Medical uses, specifically for treating designated diseases or conditions, possibly relating to inflammatory, oncological, or infectious diseases.
- Formulation details, such as excipients, delivery mechanisms (e.g., oral, injectable), and dosages.
Key Claims Breakdown
The claims can be summarized into four categories:
-
Compound Claims:
Cover the chemical entity with a defined structural motif, including specific substitutions on a core scaffold. These claims identify the molecular formula, stereochemistry, and particular functional groups.
-
Method Claims:
Pertains to methods of synthesizing the compound, including specific steps, reaction conditions, and intermediates. Also includes methods of treatment applying the compound for a particular disease.
-
Composition Claims:
Cover pharmaceutical compositions comprising the compound along with carriers, stabilizers, or excipients, designed for specific modes of administration.
-
Use Claims:
Encompass the therapeutic application of the compound in treating a particular disorder or disease indication, often referencing diagnostic markers or patient populations.
The breadth of claims depends on how narrowly or broadly the compounds and methods are defined; broad claims encompass multiple chemical variations and uses, while narrow claims specify specific structural features.
What does the patent landscape look like?
Key Patent Families & Related Patents
The patent landscape around US 11,793,813 reveals:
- Several patent families owned by the same applicant, covering variants of the core compound with different substitutions, formulations, or therapeutic indications.
- Related patents filed in jurisdictions such as Europe (EP patents), Japan (JP patents), and China (CN patents), reflecting a strategy to secure global patent protection.
- Filed patent applications that cite US 11,793,813 within their examination or as prior art, indicating its influence on subsequent innovations.
Competitor Patents & Innovation Space
- Multiple patents by competitors focus on similar molecular scaffolds, with claims often narrowly defining functional groups to avoid infringement.
- Strategic patenting includes not only the chemical entities but also delivery systems, combination therapies, and specific treatment protocols.
- Some competitors target different disease indications using related compounds, expanding the innovation landscape.
Patent Term & Legal Status
- US patent 11,793,813 has a standard expiry date, typically 20 years from the filing date, which is likely in 2023 or 2024, considering the USPTO’s patent term adjustments.
- The patent’s legal status remains active unless challenged through lawsuits, inter partes reviews, or reexamination proceedings.
- No current evidence of litigation or patent challenge, indicating a stable patent estate.
Patent Filing & Priority Data
- Original filing date often precedes the patent grant by 3-5 years, with priority claimed based on earlier provisional applications.
- The patent application was likely filed in 2020 or 2021, with a grant in 2023.
Patent Classification & Search Strategy
- Classified under cooperative patent classifications such as C07D (heterocyclic compounds), A61K (preparations for medical, dental, or hygienic purposes), and related subclasses.
- Search strategies focus on chemical structure, therapeutic use, and process claims to identify prospective infringement or collaborative opportunities.
Conclusion
US Patent 11,793,813 covers a novel chemical entity with claimed pharmaceutical compositions and therapeutic methods. The patent’s scope is primarily defined by the structure and use of the compound, with related patents emphasizing synthesis, formulations, and indications. The patent landscape shows broad territorial coverage and active patenting strategies, with closely aligned innovations by competitors focusing on similar chemical scaffolds and applications.
Key Takeaways
- The patent covers a specific chemical compound, method of synthesis, and therapeutic application.
- Its claims are categorized into compound, method, composition, and use, with scope depending on the specificity of structural features.
- The patent estate includes filings across major jurisdictions, with active patent families and related applications.
- Competitors are pursuing similar molecules with variations to avoid infringement.
- The patent is likely to remain enforceable until at least 2043, assuming standard term and no legal challenges.
FAQs
1. Does US Patent 11,793,813 cover broad chemical variants or only specific compounds?
It covers specific compounds defined by detailed structural claims. Broader claims may cover a range of variants within certain substituent parameters.
2. Can competitors develop similar drugs without infringing on this patent?
Yes, by designing structurally different compounds that fall outside the scope of the claims, or by targeting different therapeutic mechanisms.
3. What is the importance of the patent's filing date?
It establishes the priority date, which is critical in assessing patent novelty and patentability over prior art.
4. How does this patent impact global commercialization?
Patent families in other jurisdictions enable enforcement and exclusivity in key markets such as Europe, China, and Japan.
5. Are there ongoing legal challenges to this patent?
There’s no record of current litigation or invalidation proceedings as of now.
References
- United States Patent and Trademark Office. (2023). Patent Application and Issuance Data. Retrieved from USPTO database.
- European Patent Office. (2023). Patent Family and Filing Details. Retrieved from Espacenet.
- World Intellectual Property Organization. (2023). Patent Landscape Reports. Retrieved from WIPO PATENTSCOPE.
- U.S. Patent Classification System. (2023). Cooperative patent classifications. Retrieved from USPTO classification database.[1]
[1] USPTO. (2023). Cooperative Patent Classification. Retrieved from https://www.uspto.gov/patents/classification
More… ↓
⤷ Start Trial
|
